关于我们

投稿

审稿

Open Access Article

Engineering Construction & Innovation DOI: .

Standardized Operation and Control Countermeasures for VOCs Waste Gas and High-Concentration Wastewater in Pharmaceutical Enterprises
制药企业VOCs废气与高浓度废水规范化运行管控对策

作者: 赵晓源 谢彤彤 单位:杭州中美华东制药有限公司

*通讯作者:

发布时间: 2026-07-15 总浏览量: 1

摘要

制药行业会产生大量污染,生产过程也有不少安全风险。生产过程会排出VOCs废气,还有高浓度有机废水,这 类污染物成分复杂,毒性大,可生化性差,排放波动也大,当前环保监管与企业规范化运行要处理这类问题,难度不 小。本文研究制药企业对 VOCs 废气和高浓度废水的全过程管控,结合国家现行标准与工程实践数据,梳理废气和废 水的排放特征,当前治理的情况,以及治理环节比较突出的问题,搭建起覆盖源头减量,分类收集,高效治理,稳定 运行,智能监控和合规台账的一体化规范化管控体系,针对不同工艺不同场景,提出可以落地实施的运行管控办法, 还配套了典型工艺参数,运行记录表与绩效指标图表,能帮助制药企业实现稳定达标,节能降耗,控制风险,完善合 规台账,给出对应的技术支持和管理方向。 

关键词: 制药企业;VOCs废气;高浓度废水;规范化运行;管控对策

Abstract

The pharmaceutical industry generates a large amount of pollution, and its production processes also involve many safety risks. VOCs waste gas and high-concentration organic wastewater are discharged during production. These pollutants are characterized by complex components, high toxicity, poor biodegradability, and large fluctuations in emissions, making them difficult to manage under current environmental supervision requirements and standardized enterprise operation. This paper studies the whole-process control of VOCs waste gas and high-concentration wastewater in pharmaceutical enterprises. Based on current national standards and engineering practice data, it summarizes the emission characteristics, current treatment status, and prominent problems in waste gas and wastewater treatment. An integrated standardized control system covering source reduction, classified collection, efficient treatment, stable operation, intelligent monitoring, and compliance records is established. For different processes and application scenarios, practical operation and control measures are proposed, supplemented by typical process parameters, operation record forms, and performance indicator charts. The study can help pharmaceutical enterprises achieve stable compliance with emission standards, save energy and reduce consumption, control risks, and improve compliance records, providing corresponding technical support and management direction. 

Key words: pharmaceutical enterprise; VOCs waste gas; high-concentration wastewater; standardized operation; control countermeasures

参考文献 References

[1]段越,罗学刚.制药废水的响应面法优化O3/Fe-C微电解预处理工艺[J].净水技术,2023,42(2):109-116. 

[2]陈水平,邓麟凤,胡素萍,等.一种制药行业污水处理废气无组织收集生物净化处理工艺[J].中国科技信息,2024(3):80-83. 

[3]尹晓辉.制药工业建设项目环境影响评价污染防治措施要点思考[J].山东化工,2025,54(4):267-270. 

[4]张玉琳,罗双艳,赵亚娴,等.抗生素制药企业废水处理全过程中毒性评价[J].生态毒理学报,2025,20(2):161-170. 

[5]郑少杰.铁碳微电解-Fenton-水解-改良型AO工艺处理制药废水实例[J].给水排水,2025,51(7):89-94,102. 

[6]许敏,陈晓倩,陆一峰,等.不同生产类型制药废水的综合毒性评估[J].环境污染与防治,2025,47(7):101-108. 

[7]蔡升云,钱俊伟.两级 AO/MBR-絮凝沉淀-反硝化滤池工艺处理发酵制药废水[J].工业水处理,2025,45(6):227-233. 

[8]朱华旭,唐志书,李博,等.中药制药废水膜法处理的"零排放"技术方案及其实现途径探讨[J].南京中医药大学学报,2020,36(5):579-583. 

[9]高健磊,柳振铎,闫怡新,等.磁混凝-UV/O3深度处理诺氟沙星制药废水工艺研究[J].工业水处理,2023,43(5):44-51. 

[10]段西兵,乔琪,徐奇.UASB‒HBF‒UF/NF/DM 工艺处理化学制药废水[J].工业水处理,2022,42(3):178-182. 

引用本文